Patient (pt)-reported function and symptoms in APHINITY: A randomized comparison of chemotherapy (C) + trastuzumab (H) + placebo (Pla) versus C + H + pertuzumab (P) as adjuvant therapy in pts with HER2-positive early breast cancer (EBC) Meeting Abstract


Authors: Baselga, J.; Petersen, J. A.; Clark, E.; Barton, C.; Restuccia, E.; Procter, M. J.; Sonnenblick, A.; Fumagalli, D.; Parlier, D.; Arahmani, A.; Viale, G.; Reaby, L. L.; Frank, E.; Gelber, R. D.; Piccart-Gebhart, M. J.; Bines, J.; von Minckwitz, G.; Gasper, S. M.
Abstract Title: Patient (pt)-reported function and symptoms in APHINITY: A randomized comparison of chemotherapy (C) + trastuzumab (H) + placebo (Pla) versus C + H + pertuzumab (P) as adjuvant therapy in pts with HER2-positive early breast cancer (EBC)
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 14s
Language: English
ACCESSION: WOS:000442916000033
DOI: 10.1200/JCO.2018.36.15_suppl.521
PROVIDER: wos
Notes: Meeting Abstract: 521 -- Source: Wos
Altmetric Score
MSK Authors
  1. Jose T Baselga
    389 Baselga